Hunter, P.Modumo, J.Boomker, Jacob Diederik Frederik2012-12-122012-12-1220122001Hunter, P & Modumo, J 2001, 'A monovalent attenuated serotype 2 bluetongue virus vaccine confers homologous protection in sheep’. Onderstepoort Journal of Veterinary Research, vol. 68, no. 4, pp. 331-333.0030-2465http://hdl.handle.net/2263/20687The articles have been scanned in colour with a HP Scanjet 5590; 600dpi. Adobe Acrobat v.9 was used to OCR the text and also for the merging and conversion to the final presentation PDF-format.An outbreak of bluetongue caused by bluetongue virus serotype 2 virus in certain Mediterranean countries during 1999/2000, presented an opportunity to produce a monovalent type 2 vaccine. Since no data have been published previously on the protection conferred by the current live attenuated bluetongue vaccine strains used in the polyvalent vaccine, a challenge experiment was performed to determine the degree of homologous protection induced by the type 2 vaccine strain. The standard vaccine dose of 5X10⁴ pfu of vaccine conferred 99.7% protection against clinical disease and no viraemia was detected in the vaccinates.© ARC-Onderstepoort and Faculty of Veterinary Science, University of Pretoria (original). © University of Pretoria. Dept of Library Services (digital).Veterinary medicineAttenuatedBluetongue vaccineMediterranean countriesMonovalentSerotype 2Veterinary medicine -- South AfricaArticle